Leaflet BYANNLI 700mg prolonged-release suspension for injection
Indicated for: schizophrenia; bipolar disorder
Route of administration: injectable
Substance: paliperidone (antipsychotic)
ATC: N05AX13 (Nervous system | Antipsychotics | Other antipsychotics)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
This medicine may increase the risk of seizures.
This medicine may cause drowsiness or reduced alertness.
Paliperidone is an antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. It belongs to the class of atypical antipsychotics and works by regulating the activity of neurotransmitters in the brain, such as dopamine and serotonin.
The medication is administered orally or as long-acting injectable formulations, as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.
Side effects may include drowsiness, dizziness, weight gain, gastrointestinal disturbances, or, in rare cases, neuroleptic malignant syndrome.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of paliperidone.
General data about BYANNLI 700mg
- Substance: paliperidone
- Date of latest medicines list: 01-06-2026
- Product code: W68385001
- Concentration: 700mg
- Pharmaceutical form: prolonged-release suspension for injection
- Quantity: 1
- Product type: Original
- Price: 4585.70 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for paliperidone
Concentrations available for paliperidone
- 1000mg
- 100mg
- 12mg
- 150mg
- 175mg
- 25mg
- 263mg
- 350mg
- 3mg
- 50mg
- 525mg
- 6mg
- 700mg
- 75mg
- 9mg